Susan Kahn - Dec 21, 2021 Form 4 Insider Report for LogicBio Therapeutics, Inc. (LOGC)

Role
Director
Signature
/s/ Andrea Paul, as Attorney-in-Fact
Stock symbol
LOGC
Transactions as of
Dec 21, 2021
Transactions value $
$0
Form type
4
Date filed
12/23/2021, 08:14 AM
Next filing
Jun 21, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LOGC Stock Option (right to buy) Award $0 +25K $0.00 25K Dec 21, 2021 Common Stock 25K $2.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted pursuant to the Issuer's non-employee director compensation policy in connection with the Reporting Person's appointment as a member of the Issuer's Board of Directors. The options will vest over three years as follows: one third (1/3) of the shares underlying the options will vest on each of the first, second and third anniversaries of the grant date.